Our TB drug discovery team has showcased the TB community's unwavering dedication in eradicating and managing tuberculosis with an impactful depiction that highlights their tireless efforts. Stop TB Partnership @WorldTBDay2025

The endless research for TB drug discovery to combat emergence of drug-resistance. #Together we can Stop TB Partnership #YesWeCanEndTB.

TB Warriors in action: "Advancing research for a TB free world". As warriors against Tuberculosis, researchers are driving the fight forward by developing effective treatments & advancing global health. The battle continues & we won't stop until we win! #YesWeCanEndTB Stop TB Partnership

This week's inside front cover features a Review article by Rashmi Sharma & co on the importance of ATP synthase in Mycobacterium tuberculosis and its potential as a drug target, take a look🌟 pubs.rsc.org/en/content/art… 📍 CSIR-IIIM

Glad to share our recent cover art in RSC Medchem… kudos to Summaya Perveen and Sunny Pal for their amazing contributions

Delighted to announce that our photograph for World TB Day photo contest 2025 by Stop TB Partnership has been selected as one of the winning entries. Congratulations to my whole team for achieving this milestone. CSIR-IIIM Rashmi Sharma

Summaya Perveen sapna saini Anjali Gangwar Rabia Mushtaq

Congratulations to Anjali Negi, PhD Scholar at #CSIRIIIM #Jammu, for winning the World TB Day 2025 Photo Contest! 🏆 Her stunning photograph captured the essence of this year's theme: "Yes! We Can End TB: Commit, Invest, Deliver." 🌍👏 #WorldTBDay2025 #TBawareness

Congratulations to the team; the team collaborated, brainstormed ideas and submitted 5 photos - one of which got selected ; really proud Stop TB Partnership World Health Organization (WHO)

CSIR-NIScPR Congratulates Anjali Negi, PhD Scholar at CSIR-IIIM for winning the World TB Day 2025 Photo Contest! 🏆 Her powerful photo embodies the theme "Yes! We Can End TB: Commit, Invest, Deliver". #EndTB

ICMR project Scientist position available in my group ; candidates with experience in BSL3 lab would be preferred ; apply now iiim.res.in/wp-content/upl…

New research in #JMedChem highlights promising compounds that could lead to safer, more effective treatments for tuberculosis—including drug-resistant forms. A major step forward in the global fight against TB Rashmi Sharma Parvinder Pal Singh CSIR-IIIM go.acs.org/cMB

Glad to share our recent work in #JMedChem

Excited to share that two senior scholars of our group Summaya Perveen Anjali Negi are presenting their work at #GRC #TB in Barcelona… If you're attending, be sure to catch their work and say hello! #mycobacteria #tuberculosis #drugdevelopment

The latest issue of #JMedChem is now out! go.acs.org/d8I In the cover story by Negi et al., the authors describe the identification of novel quinoline and quinazoline compounds with promising anti-TB potency.

Pleased to share that our cover art is featured in JMC; In the cover story, we explore novel hits with anti TB Potency #JMC #TBResearch ACS Publications Bio & Med Chem Content Congratulations to the team Anjali Negi Summaya Perveen Harpreet kour Parvinder Pal Singh

🎓✨ A proud moment for our group! Huge congratulations to Dr. Summaya Parveen Summaya Perveen , the first PhD from our lab, on a successful thesis defense! Your hard work, resilience, and passion have truly paved the way. Here’s to many more! 🥳💐 #PhDJourney #ProudSupervisor

Officially Dr. Summaya Perveen💫💫 I’m thrilled to share that I have successfully defended my PhD on 17.09.2025 This journey has been one of immense growth and learning. I am thankful to my supervisor Dr. Rashmi Sharma for her unwavering support. Here’s to #NewBegginnings✨

✍️WHO now recommends a 6-month all-oral regimen for drug-resistant TB: shorter, safer, and easier to complete. A major step forward in global TB care. 📄 Full update: who.int/news/item/15-0… #TB #GlobalHealth